Justin G. James

Justin G. James

Auto-generated profile, based on publicly available information

Justin G. James

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2026 in Nature
Verified
Journal Article
Open access
PDF file
COCorinna S. Oswell
Corinna S. Oswell
SRSophie A. Rogers
Sophie A. Rogers
JJJustin G. James
Justin G. James
NMNora M. McCall
Nora M. McCall
AHAlex I. Hsu
Alex I. Hsu
GCGregory Corder
Gregory Corder
The anterior cingulate cortex is a key brain region involved in the affective and motivational dimensions of pain, but how opioid analgesics modulate this cortical circuit remains unclear1. Uncovering how opioids alter nociceptive neural dynamics to produce pain relief is essential for developing safer and more targeted treatments for chronic pain. Here we show that a population of cingulate neurons encodes spontaneous pain-related behaviours and is selectively modulated by morphine. Using deep learning behavioural analyses combined with longitudinal neural recordings in mice, we identified a persistent shift in cortical activity patterns following nerve injury that reflects the emergence of an unpleasant, affective chronic pain state. Morphine reversed these neuropathic neural dynamics and reduced affective–motivational behaviours without altering sensory detection or reflexive responses, mirroring how opioids alleviate pain unpleasantness in humans. Leveraging these findings, we built a biologically inspired chemogenetic gene therapy that targets opioid-sensitive neurons in the cingulate using a synthetic μ-opioid receptor promoter to drive inhibition2. This opioid-mimetic chemogenetic gene therapy recapitulated the analgesic effects of morphine during chronic neuropathic pain, thereby offering a new strategy for precision pain management that targets a key nociceptive cortical opioid circuit with safe, on-demand analgesia.

3 May 2024 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
TTThomas F. Tropea
Thomas F. Tropea
WHWhitney Hartstone
Whitney Hartstone
NANoor Amari
Noor Amari
DBDylan Baum
Dylan Baum
JRJacqueline Rick
Jacqueline Rick
ACAlice S. Chen-Plotkin
Alice S. Chen-Plotkin
Observational studies in Parkinson’s disease (PD) deeply characterize relatively small numbers of participants. The Molecular Integration in Neurological Diagnosis Initiative seeks to characterize molecular and clinical features of every PD patient at the University of Pennsylvania (UPenn). The objectives of this study are to determine the feasibility of genetic characterization in PD and assess clinical features by sex and GBA1/LRRK2 status on a clinic-wide scale. All PD patients with clinical visits at the UPenn PD Center between 9/2018 and 12/2022 were eligible. Blood or saliva were collected, and a clinical questionnaire administered. Genotyping at 14 GBA1 and 8 LRRK2 variants was performed. PD symptoms were compared by sex and gene groups. 2063 patients were approached and 1,689 (82%) were enrolled, with 374 (18%) declining to participate. 608 (36%) females were enrolled, 159 (9%) carried a GBA1 variant, and 44 (3%) carried a LRRK2 variant. Compared with males, females across gene groups more frequently reported dystonia (53% vs 46%, p = 0.01) and anxiety (64% vs 55%, p < 0.01), but less frequently reported cognitive impairment (10% vs 49%, p < 0.01) and vivid dreaming (53% vs 60%, p = 0.01). GBA1 variant carriers more frequently reported anxiety (67% vs 57%, p = 0.04) and depression (62% vs 46%, p < 0.01) than non-carriers; LRRK2 variant carriers did not differ from non-carriers. We report feasibility for near-clinic-wide enrollment and characterization of individuals with PD during clinical visits at a high-volume academic center. Clinical symptoms differ by sex and GBA1, but not LRRK2, status.

1 June 2023 in Neurology Clinical Practice
Verified
Journal Article
Closed access
JJJustin G. James
Justin G. James
JPJane Park
Jane Park
AOAlexandria Oliver
Alexandria Oliver
SXSharon X. Xie
Sharon X. Xie
ASAndrew Siderowf
Andrew Siderowf
TTThomas Tropea
Thomas Tropea
Background and ObjectivesTeleneurology is common in clinical practice partly due to the SARS CoV-2 pandemic. Impressions about teleneurology from patients and providers alike are generally favorable; some of the reported benefits include ease of access to ...

1 June 2024 in Neurology Clinical Practice
Verified
Journal Article
Closed access
JJJustin G. James
Justin G. James
LWLawrence R. Wechsler
Lawrence R. Wechsler
CBChristina A. Blum
Christina A. Blum
CBCharles J. Bae
Charles J. Bae
TTThomas Tropea
Thomas Tropea
Teleneurology usage has increased during the severe acute respiratory syndrome coronavirus 2 pandemic. However, studies evaluating physician impressions of inpatient teleneurology are limited. We implemented a quality improvement initiative to evaluate neurologists' impression following individual inpatient teleneurology consultation at a satellite hospital of a large academic center with no in-person neurology coverage. A REDCap survey link was embedded within templates used by neurologists for documentation of inpatient consultations to be completed immediately after encounters. All teleneurology encounters with completed surveys at a single satellite hospital of the University of Pennsylvania Health System Neurology Department between May 10, 2021, and August 14, 2022, were included. Individual patient-level and encounter-level data were extracted from the medical record. A total of 374 surveys (response rate of 54.05%) were completed by 19 neurologists; 341 questionnaires were included in the analysis. Seven neurologists who specialized as neurohospitalists completed 231 surveys (67.74% of total surveys completed), while 12 non-neurohospitalists completed 110 (32.36%). The history obtained was rated as worse (14%) or the same (86%) as an in-person consult; none reported the history as better than nonteleneurology encounters. The physician-patient relationship was poor or fair in 25% of the encounters and good or excellent in 75% of visits. The overall experience was judged to be worse than in-person consultation in 32% of encounters, the same in 66%, and better in 2%. Fifty-one percent of providers responded that there were elements of the neurologic examination that might have changed their assessment and plan of care if performed in-person. Encounters with peripheral or neuromuscular-related chief complaints had the most inadequate examinations and worse overall experiences, while the most positive impressions of these clinical experiences were observed among seizure-related chief complaints. Determining best practices for inpatient teleneurology should consider the patient chief complaint to use teleneurology in scenarios with the highest likelihood of a positive experience. Further efforts should be made to the patient experience and to improve the remote examination to enhance the applicability of teleneurology to the full spectrum of inpatient neurologic consultations.

31 July 2025 in bioRxiv
Verified
Preprint
Open access
SCSavanna A. Cohen
Savanna A. Cohen
LWLisa M. Wooldridge
Lisa M. Wooldridge
JJJustin J. James
Justin J. James
JWJacqueline W. K. Wu
Jacqueline W. K. Wu
GCGregory F. Corder
Gregory F. Corder
Understanding opioid withdrawal behaviors in preclinical models is critical to improving therapeutic approaches for opioid use disorder (OUD). However, quantifying these withdrawal behaviors remains a difficult process for researchers, given the subtlety of behaviors and variation across individuals. To overcome these difficulties, we developed a scalable behavioral analysis pipeline using LUPE (Light aUtomated Pain Evaluator), an open-source framework integrating video acquisition, pose estimation, supervised and unsupervised classification, and expert-guided behavior discovery. Mice undergoing naloxone-precipitated opioid withdrawal were recorded and analyzed using DeepLabCut for markerless pose estimation. We hand-annotated withdrawal-specific behaviors, including jumping, genital licking, grooming, and paw tremors, and normal behaviors, including walking, rearing, and being still, using Behavioral Observation Research Interactive Software (BORIS) to generate frame-by-frame ethograms. The annotations and pose data were then imported into Active learning Segmentation of Open field in DeepLabCut (A-SOiD), an active learning platform for behavior classification. A-SOiD successfully detected some behaviors (e.g., grooming and rearing) which were of a longer duration, though other rapid behaviors (e.g., jumping and paw tremors) were inconsistently captured. While no novel behavioral motifs have been discovered yet, ongoing work aims to refine model performance. This LUPE-based pipeline sets the groundwork for standardized, high-resolution behavior quantification and is being applied to additional datasets to investigate whether new components of the withdrawal phenotype emerge across experimental conditions.

9 December 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JJJustin G. James
Justin G. James
JPJane Park
Jane Park
AOAlexandria Oliver
Alexandria Oliver
SXSharon X. Xie
Sharon X. Xie
ASAndrew Siderowf
Andrew Siderowf
TTThomas Tropea
Thomas Tropea
Background and Objectives: Teleneurology is common in clinical practice partly due to the SARS CoV-2 pandemic. Impressions about teleneurology from patients and providers alike are generally favorable; some of the reported benefits include ease of access to specialized healthcare, savings of time and money, and similar quality of care as an in-person visit. However, comparisons between patient and provider impressions about the same teleneurology encounter have not been described. Here we describe patient impressions about a teleneurology encounter and evaluate concordance with provider impressions about the same encounter. Methods: Patients and providers at the University of Pennsylvania Hospital Neurology Department were surveyed about their impressions of teleneurology between April 27 th and June 16 th , 2020. A convenience sample of patients, whose providers completed a questionnaire, were contacted by telephone to solicit their impressions the same encounter. Unique questionnaires for patients and providers focused on similar themes, such as adequacy of technology, assessment of history obtained, and overall quality of the visit. Summaries of patient responses are reported with the raw percent agreement between patients and providers for similar questions. Results: One hundred thirty-seven patients completed the survey; 64 (47%) were male and 73 were (53%) female. Sixty-six (47%) patients had a primary diagnosis of PD, 42 (30%) a non-PD movement disorder, and 29 (21%) a non-movement disorder neurological disease. One hundred one (76%) were established patient visits and 36 (26%) were new patient visits. Provider responses from 8 different physicians were included. The majority of patients responded that the ease of joining their visit, their comfort engaging with their physicians during their visit, understanding their plan of care after their visit, and the quality of care from their teleneurology visit were satisfactory. Patients and providers agreed about their impressions of the quality of the history obtained (87% agreement), patient-provider relationship (88% agreement), and overall quality of their experience (70% agreement). Discussion: Patients had favorable impressions about their clinical experience with teleneurology and expressed an interest in incorporating telemedicine visits into their ongoing care. Patients and providers were highly concordant for the history obtained, patient-provider relationship, and overall quality.